MARKET

INMD

INMD

Inmode Ltd.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

24.14
+1.32
+5.78%
After Hours: 24.72 +0.58 +2.40% 19:54 06/24 EDT
OPEN
23.31
PREV CLOSE
22.82
HIGH
24.14
LOW
22.88
VOLUME
1.23M
TURNOVER
0
52 WEEK HIGH
99.27
52 WEEK LOW
20.60
MARKET CAP
2.01B
P/E (TTM)
12.28
1D
5D
1M
3M
1Y
5Y
InMode launches women wellness device EmpowerRF in Canada following regulator nod
InMode (NASDAQ:INMD) launched EmpowerRF device for women wellness in Canada. The company said it recently received Health Canada certification to improve urinary incontinence symptoms, adding to previous licenses for improving the
Seekingalpha · 06/15 13:54
InMode Receives Health Canada Certification of EmpowerRF Women's Wellness Technology
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is proud to announce the EmpowerRF Women's Wellness launch in Canada. InMode has recently received Health Canada certification to improve urinary incontinence symptom...
PR Newswire · 06/15 12:03
Jim Cramer Likes This Stock Over Olaplex
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Danaher Corporation (NYSE: DHR) over InMode Ltd. (NASDAQ: INMD).
Benzinga · 06/02 12:15
CNCE, AVIR and INMD are among after hour movers
Gainers: Elevation Oncology (ELEV) +9%. INMODE  (INMD) +6%. Inspirato Incorporated (ISPO) +5%. Ranger Oil Corporation (ROCC) +5%. Anavex Life Sciences  (AVXL) +5%. Losers: Concert Pharmaceuticals (CNCE) -17%. Chindata Group Holdings Limited (CD)
Seekingalpha · 05/31 21:43
InMode to Participate at the UBS Healthcare One-on-One Virtual Day
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer, will participate at the UBS Healthcare One-on-One Virtual Day on ...
PR Newswire · 05/23 12:00
11 Key Quarterly Reports to Watch
In this article, we will take a look at the 11 key quarterly reports to watch. You can skip our detailed analysis of these companies and go directly to the 5 Key Quarterly Reports to Watch. Stocks from the consumer cyclical and basic materials sectors, inc...
Insider Monkey · 05/03 16:54
The one-year underlying earnings growth at InMode (NASDAQ:INMD) is promising, but the shareholders are still in the red over that time
It's easy to match the overall market return by buying an index fund. But if you buy individual stocks, you can do both...
Simply Wall St. · 05/03 14:37
--Needham Adjusts InMode's Price Target to $58 From $82 on 'Peer Multiple Compression,' Reiterates Buy Rating
MT Newswires · 05/03 05:03
More
No Data
Learn about the latest financial forecast of INMD. Analyze the recent business situations of Inmode Ltd. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

66.67%Strong Buy
33.33%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average INMD stock price target is 55.00 with a high estimate of 58.00 and a low estimate of 50.00.
High58.00
Average55.00
Low50.00
Current 24.14
EPS
Actual
Estimate
0.160.320.480.64
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 361
Institutional Holdings: 49.49M
% Owned: 59.57%
Shares Outstanding: 83.08M
TypeInstitutionsShares
Increased
143
10.43M
New
55
2.85M
Decreased
91
6.31M
Sold Out
83
2.91M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.64%
Healthcare Equipment & Supplies
+2.14%
Key Executives
Chairman/Chief Executive Officer/Director
Moshe Mizrahy
Chief Financial Officer
Yair Malca
Corporate Executive
Shakil Lakhani
Chief Technology Officer/Director
Michael Kreindel
Other
Spero Theodorou
Independent Director
Michael Anghel
Independent Director
Bruce Mann
Independent Director
Hadar Ron
No Data
No Data
About INMD
Inmode Ltd is an Israel-based company. It designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. It owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.

Webull offers kinds of Inmode Ltd stock information, including NASDAQ:INMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INMD stock methods without spending real money on the virtual paper trading platform.